Astroglial Connexin43 As a Potential Target for a Mood Stabiliser

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jan 5

PMID 33396966

Citations 18

Authors

Motohiro Okada

Tomoka Oka

Misaki Nakamoto

Kouji Fukuyama

Takashi Shiroyama

Affiliations

Soon will be listed here.

Abstract

Mood disorders remain a major public health concern worldwide. Monoaminergic hypotheses of pathophysiology of bipolar and major depressive disorders have led to the development of monoamine transporter-inhibiting antidepressants for the treatment of major depression and have contributed to the expanded indications of atypical antipsychotics for the treatment of bipolar disorders. In spite of psychopharmacological progress, current pharmacotherapy according to the monoaminergic hypothesis alone is insufficient to improve or prevent mood disorders. Recent approval of esketamine for treatment of treatment-resistant depression has attracted attention in psychopharmacology as a glutamatergic hypothesis of the pathophysiology of mood disorders. On the other hand, in the last decade, accumulated findings regarding the pathomechanisms of mood disorders emphasised that functional abnormalities of tripartite synaptic transmission play important roles in the pathophysiology of mood disorders. At first glance, the enhancement of astroglial connexin seems to contribute to antidepressant and mood-stabilising effects, but in reality, antidepressive and mood-stabilising actions are mediated by more complicated interactions associated with the astroglial gap junction and hemichannel. Indeed, several depressive mood-inducing stress stimulations suppress connexin43 expression and astroglial gap junction function, but enhance astroglial hemichannel activity. On the other hand, monoamine transporter-inhibiting antidepressants suppress astroglial hemichannel activity and enhance astroglial gap junction function, whereas several non-antidepressant mood stabilisers activate astroglial hemichannel activity. Based on preclinical findings, in this review, we summarise the effects of antidepressants, mood-stabilising antipsychotics, and anticonvulsants on astroglial connexin, and then, to establish a novel strategy for treatment of mood disorders, we reveal the current progress in psychopharmacology, changing the question from "what has been revealed?" to "what should be clarified?".

Citing Articles

Ginsenoside Rg1: A Neuroprotective Natural Dammarane-Type Triterpenoid Saponin With Anti-Depressive Properties.

Han D, Zhao Z, Mao T, Gao M, Yang X, Gao Y CNS Neurosci Ther. 2024; 30(12):e70150.

PMID: 39639753 PMC: 11621566. DOI: 10.1111/cns.70150.

The Janus face of antipsychotics in glial cells: Focus on glioprotection.

Schmitz I, da Silva A, Bobermin L, Goncalves C, Steiner J, Quincozes-Santos A Exp Biol Med (Maywood). 2024; 248(22):2120-2130.

PMID: 38230521 PMC: 10800129. DOI: 10.1177/15353702231222027.

Staphylococcus warneri strain XSB102 exacerbates psoriasis and promotes keratinocyte proliferation in imiquimod-induced psoriasis-like dermatitis mice.

Si W, Li M, Wang K, Li J, Xu M, Zhou X Arch Microbiol. 2023; 206(1):3.

PMID: 37991548 DOI: 10.1007/s00203-023-03726-2.

Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation.

Lei L, Wang Y, Hu D, Gai C, Zhang Y Cell Mol Neurobiol. 2023; 43(8):4023-4040.

PMID: 37875763 PMC: 11407732. DOI: 10.1007/s10571-023-01426-5.

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine.

Fukuyama K, Motomura E, Okada M Biomolecules. 2023; 13(9).

PMID: 37759688 PMC: 10526296. DOI: 10.3390/biom13091288.

References

Einoch R, Weinreb O, Mandiuk N, Youdim M, Bilker W, Silver H . The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol. 2017; 27(5):470-483. DOI: 10.1016/j.euroneuro.2017.03.005. View

Willner P, Scheel-Kruger J, Belzung C . The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev. 2012; 37(10 Pt 1):2331-71. DOI: 10.1016/j.neubiorev.2012.12.007. View

Fornaro M, Carvalho A, Fusco A, Anastasia A, Solmi M, Berk M . The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. J Affect Disord. 2020; 276:970-983. DOI: 10.1016/j.jad.2020.07.109. View

Bahji A, Ermacora D, Stephenson C, Hawken E, Vazquez G . Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis. J Affect Disord. 2020; 269:154-184. DOI: 10.1016/j.jad.2020.03.030. View

Quesseveur G, Portal B, Basile J, Ezan P, Mathou A, Halley H . Attenuated Levels of Hippocampal Connexin 43 and its Phosphorylation Correlate with Antidepressant- and Anxiolytic-Like Activities in Mice. Front Cell Neurosci. 2016; 9:490. PMC: 4686612. DOI: 10.3389/fncel.2015.00490. View

Wang F, Qi X, Zhang J, Huang J . Astrocytic modulation of potassium under seizures. Neural Regen Res. 2019; 15(6):980-987. PMC: 7034283. DOI: 10.4103/1673-5374.270295. View

Dambach H, Hinkerohe D, Prochnow N, Stienen M, Moinfar Z, Haase C . Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation. Epilepsia. 2013; 55(1):184-92. DOI: 10.1111/epi.12473. View

Takeuchi H, Suzumura A . Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases. Front Cell Neurosci. 2014; 8:189. PMC: 4151093. DOI: 10.3389/fncel.2014.00189. View

Fukuyama K, Fukuzawa M, Okubo R, Okada M . Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant α4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy. Pharmaceuticals (Basel). 2020; 13(4). PMC: 7243124. DOI: 10.3390/ph13040058. View

10.

Garbelli R, Frassoni C, Condorelli D, Trovato Salinaro A, Musso N, Medici V . Expression of connexin 43 in the human epileptic and drug-resistant cerebral cortex. Neurology. 2011; 76(10):895-902. DOI: 10.1212/WNL.0b013e31820f2da6. View

11.

Quesseveur G, Gardier A, Guiard B . The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Curr Drug Targets. 2013; 14(11):1277-94. DOI: 10.2174/13894501113149990209. View

12.

Taylor D, Cornelius V, Smith L, Young A . Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatr Scand. 2014; 130(6):452-69. DOI: 10.1111/acps.12343. View

13.

Reus G, Abelaira H, Agostinho F, Ribeiro K, Vitto M, Luciano T . The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain. J Psychiatr Res. 2012; 46(8):1029-35. DOI: 10.1016/j.jpsychires.2012.04.016. View

14.

Escudero M, Gutierrez-Rojas L, Lahera G . Second Generation Antipsychotics Monotherapy as Maintenance Treatment for Bipolar Disorder: a Systematic Review of Long-Term Studies. Psychiatr Q. 2020; 91(4):1047-1060. DOI: 10.1007/s11126-020-09753-2. View

15.

Mostafavi H, Khaksarian M, Joghataei M, Hassanzadeh G, Soleimani M, Eftekhari S . Fluoxetin upregulates connexin 43 expression in astrocyte. Basic Clin Neurosci. 2014; 5(1):74-9. PMC: 4202606. View

16.

Yatham L, Kennedy S, Parikh S, Schaffer A, Bond D, Frey B . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018; 20(2):97-170. PMC: 5947163. DOI: 10.1111/bdi.12609. View

17.

Li Q, Li Q, Jia J, Liu Z, Zhou H, Mao X . Targeting gap junction in epilepsy: Perspectives and challenges. Biomed Pharmacother. 2018; 109:57-65. DOI: 10.1016/j.biopha.2018.10.068. View

18.

Fukuyama K, Fukuzawa M, Shiroyama T, Okada M . Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor. Br J Pharmacol. 2020; 177(9):2143-2162. PMC: 7161548. DOI: 10.1111/bph.14974. View

19.

Bernard R, Kerman I, Thompson R, Jones E, Bunney W, Barchas J . Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry. 2010; 16(6):634-46. PMC: 2927798. DOI: 10.1038/mp.2010.44. View

20.

Walrave L, Vinken M, Leybaert L, Smolders I . Astrocytic Connexin43 Channels as Candidate Targets in Epilepsy Treatment. Biomolecules. 2020; 10(11). PMC: 7699773. DOI: 10.3390/biom10111578. View